XML 34 R23.htm IDEA: XBRL DOCUMENT v3.25.2
STOCKHOLDERS' DEFICIT (Tables)
 6 Months Ended
Jun. 30, 2025
Equity [Abstract]  
Schedule of Share-Based Payment Arrangement, Cost by Plan
The following table presents the Company's total share based compensation expense by award type:

(In thousands)Three Months Ended
June 30,		Six Months Ended
June 30,
2025202420252024
RSUs$4,017 $5,085 $9,345 $10,011 
Performance RSUs3,217 1,412 6,746 4,201 
Options26 723 198 1,488 
Total Share Based Compensation Expense(1)
$7,260 $7,220 $16,289 $15,700 
(1)Total share based compensation expense includes $2.6 million and $4.2 million of expense from cash settled awards for the three and six months ended June 30, 2025, respectively. Total share based compensation expense includes $0.5 million of expense from cash settled awards for the six months ended June 30, 2024. Share based compensation expense from cash settled awards was immaterial for the three months ended June 30, 2024.
Schedule of Computation of Income (Loss) per Share
Computation of Loss per Share
(In thousands, except per share data)Three Months Ended
June 30,		Six Months Ended
June 30,
 2025202420252024
NUMERATOR:    
Net loss attributable to the Company – common shares$(83,480)$(981,658)$(364,704)$(1,000,166)
DENOMINATOR(1):
   
Weighted average common shares outstanding - basic154,275 151,137 153,382 150,466 
  Stock options and restricted stock(2):
— — — — 
Weighted average common shares outstanding - diluted154,275 151,137 153,382 150,466 
Net loss attributable to the Company per common share:   
Basic$(0.54)$(6.50)$(2.38)$(6.65)
Diluted(0.54)(6.50)(2.38)(6.65)
(1)All of the outstanding Special Warrants are included in both the basic and diluted weighted average common shares outstanding of the Company for the three and six months ended June 30, 2025 and 2024.
(2)Outstanding equity service awards representing 12.6 million and 15.1 million shares of Class A common stock of the Company for the three months ended June 30, 2025 and 2024, respectively, and 14.6 million and 15.5 million shares of Class A common stock for the six months ended June 30, 2025 and 2024, respectively, were not included in the computation of diluted earnings per share because to do so would have been antidilutive.